Orpea (ORPEF) Stock Price, News & Analysis

Company Overview

Orpea S.A., now operating under the emeis brand, is a France-based healthcare and care-services company specializing in long-term care for older adults and people requiring medical or rehabilitative support. Its activities have historically included nursing homes, post-acute and rehabilitation facilities, psychiatric clinics, and related healthcare services.

The company has operated a network of facilities across several European countries, including France, Germany, Belgium, Austria, Italy, Spain and Poland, as well as selected markets outside Europe. Its services generally combine accommodation, personal assistance, nursing care, medical support and rehabilitation, depending on the type of facility.

Orpea was founded in France in 1989 and expanded through the development and acquisition of care facilities. Following financial and governance difficulties that emerged publicly in the early 2020s, the company underwent a restructuring and ownership transformation. In 2024, it adopted the emeis name as part of a broader effort to reposition the business. Laurent Guillot served as chief executive during the restructuring period.

Key Stats

• Today's Range: $6.60 to $6.60
• 50-Day Range: $6.60 to $6.60
• 52-Week Range: $6.60 to $6.60
• Volume: N/A
• Average Volume: 15,700 shs
• Market Capitalization: N/A
• P/E Ratio: 3.61
• Dividend Yield: 9.09%
• Price Target: N/A
• Consensus Rating: N/A

Orpea Stock Analysis - MarketRank™

Orpea scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Orpea.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Orpea is 3.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.52.

Price to Earnings Ratio vs. Sector

The P/E ratio of Orpea is 3.61, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 192.52.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Orpea has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Orpea has recently increased by 13.81%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Orpea pays a meaningful dividend of 1.46%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Orpea does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Orpea is 32.78%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: N/A

News Sentiment

Orpea has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Orpea this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Orpea insiders have not sold or bought any company stock.

Percentage Held by Institutions

24.98% of the stock of Orpea is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ORPEF
• CIK: N/A
• Web: www.orpea-corp.com
• Phone: (314) 775-7807
• Fax: N/A
• Employees: 76,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 3.61
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A